SCIENTIFIC RESOURCES
On-Demand Webinars

See how industry pioneers are revealing the true immune biology at each development stage

All
  • All
  • Proteomics
  • Technology
Proteomics
Speaker: Andrew Y. Koh, MD, University of Texas Southwestern Medical Center
How Gut Microbiomes Shape Anti-Tumor Immune Responses
Proteomics
Speaker: Abhishek D. Garg, PhD, Head of Laboratory of Cell Stress and Immunity Department of Cellular and Molecular Medicine at University of Leuven
The Many Facets of T Cell Exhaustion
Proteomics
Speaker: Caroline Le Poole, PhD, Professor of Dermatology and Microbiology-Immunology at Northwestern University Feinberg School of Medicine
Efficacy of Polyfunctional GD3 CAR T Cells against Rare Tumors
Proteomics
Speaker: Sean Mackay, CEO and Co-Founder, IsoPlexis
Bridging the Gap: Integrating Single-Cell Transcriptomics and Proteomics
Proteomics
Speaker: David Miklos, MD, PhD, Chief Clinical Director, Blood and Marrow Transplantation and Cellular Therapy, Cancer Cell Therapy Stanford University
Sharpening a Double-Edged Sword: Bispecific CAR-T Cancer Therapies
Technology
Speaker: Victor Tek, Senior Product Manager, IsoPlexis
Highly Multiplexed Single-Cell Proteomics Identifies Key Inflammatory Mediators in Severe COVID-19
Proteomics
Speaker: Jessica Morris, PhD Candidate, Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital Methodist Hospital
Enhancing the Efficacy of CAR-T Cell Therapies
Proteomics
Speaker: Katie Mckenna, PhD, Postdoctoral Fellow Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital Methodist Hospital
Delivery of Oncolytic Immunotherapy by MSCs Enhances CAR-T Cell Anti-Tumor Activity
Proteomics
Speaker: Rong Fan, PhD, Garry Nolan, PhD, Nikolai Slavov, PhD, Tao Liu, PhD, Christopher Rose, PhD, Bernd Bodenmiller, PhD
Advances in Single-Cell Proteomics: Building a Complete Picture of Cellular Identity
Proteomics
Speaker: James R. Heath, PhD, Professor and President of Institute of Systems Biology, Seattle, and Sean Mackay, CEO and Co-Founder, IsoPlexis
Harnessing Single-Cell Multi-Omic Energy States for Integrated Cancer Biology
Proteomics
Speaker: Sean Mackay, CEO and Co-Founder, IsoPlexis
Walk-Away High-Plex Proteomics to Enable Accelerated Immune Medicine
Proteomics
Speaker: Sean Mackay, CEO and Co-Founder, IsoPlexis
Single-Cell Phosphoproteomics: Defining the Signaling Pathways of Each Single Cell
Proteomics
Speaker: Sean Mackay, CEO and Co-Founder, IsoPlexis
Connecting Single-Cell Biology: How Harnessing the Most Powerful Immune Cells is Changing Immune Medicine
Proteomics
Speaker: Matthew Hewitt, PhD, Head of R&D (a.i.) and Clinical Development, Personalized Medicine, Lonza, and Stacey Willard, PhD, Director of Product Management, IsoPlexis
The Future of Cellular Immunotherapy: Highly Automated Precision Medicine
Proteomics
Speaker: James R. Heath, PhD, Professor and President of Institute of Systems Biology, Seattle
Improving COVID-19 Treatment & Vaccine Development by Modulating the Immune Response: Applying Single-Cell Proteomics
Technology
Speaker: Jon Chen, MS, Technology Co-Inventor, IsoPlexis
Unique Functional Biology Revealed with IsoPlexis Functional Proteomics & Single-Cell Secretome Solution
Proteomics
Speaker: Arnold Levine, PhD, Professor Emeritus, Simons Center for Systems Biology, Institute for Advanced Study
The Structure and Functions of the p53 Pathway: Information Acquisition, Redundancy, and Connectivity
Technology
Speaker: Cynthia Turcotte, PhD, Senior Director of Applications, IsoPlexis
New Functional Biology Revealed from Monocytes and Other Innate & Myeloid Cells with the Single-Cell Innate Immune Solution
Proteomics
Speaker: Shelli Farhadian, MD, PhD, Assistant Professor, Yale School of Medicine
Understanding the Role of Cytokines and Neuroinflammation in COVID-19 Patients with Neurological Manifestations
Proteomics
Speaker: Giulia Parisi, PhD, Project Scientist, Department of Microbiology, Immunology and Molecular Genetics, University of California
The Role of Single-Cell Functional Biomarkers in Next-Generation Cancer Therapies
Subscribe to Follow the Data

Weekly email to keep you at the forefront of single-cell & multiplexed proteomics.

Subscribe